Table 2. Change in cell abundance due to age, sex, and COVID-19 severity fold difference (log2) [± 95% CI].
CD4+ T* | ILC* | CD8+ T* | CD16+ NK* | |
---|---|---|---|---|
Age | –0.012*** | –0.043*** | –0.009* | 0.021*** |
[–0.018,–0.005] | [–0.053,–0.033] | [–0.016,–0.002] | [0.010, 0.032] | |
Male | –0.409*** | –0.334* | –0.177 | 0.184 |
[–0.618,–0.201] | [–0.659,–0.010] | [–0.406, 0.051] | [–0.169, 0.538] | |
Hospitalized | 0.168 | –0.835*** | 0.227 | –1.205*** |
[–0.084, 0.421] | [–1.228,–0.441] | [–0.050, 0.503] | [–1.633,–0.778] | |
Outpatient | 0.332* | –0.088 | –0.023 | –0.522* |
[0.082, 0.581] | [–0.478, 0.302] | [–0.298, 0.253] | [–0.948,–0.095] | |
R2 | 0.275 | 0.478 | 0.070 | 0.232 |
*p< 0.05, **p < 0.01, ***p < 0.001.
per 106 lymphocytes.